Proteinuria and its relation to cardiovascular disease

References

• SarnakMJLeveyASSchoolwerthACAmerican Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventionKidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventionCirculation2003108172154216914581387
   PubMed Web of Science ®Google Scholar
• AgrawalVMarinescuVAgarwalMMcCulloughPACardiovascular implications of proteinuria: an indicator of chronic kidney diseaseNat Rev Cardiol20096430131119352334
   PubMed Web of Science ®Google Scholar
• WagnerDKHarrisTMadansJHProteinuria as a biomarker: risk of subsequent morbidity and mortalityEnviron Res19946621601728055838
   PubMed Web of Science ®Google Scholar
• GargAXKiberdBAClarkWFHaynesRBClaseCMAlbuminuria and renal insufficiency prevalence guides population screening: results from the NHANES IIIKidney Int20026162165217512028457
   PubMed Web of Science ®Google Scholar
• CulletonBFLarsonMGParfreyPSKannelWBLevyDProteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective studyAm J Med200010911810936471
   PubMed Web of Science ®Google Scholar
• SeguraJCampoCRuilopeLMProteinuria: an underappreciated risk factor in cardiovascular diseaseCurr Cardiol Rep20024645846212379163
   PubMedGoogle Scholar
• LjungmanSWikstrandJHartfordMBerglundGUrinary albumin excretion – a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive menAm J Hypertens1996987707788862223
   PubMed Web of Science ®Google Scholar
• KashifWSiddiqiNDincerAPDincerHEHirschSProteinuria: how to evaluate an important findingCleve Clin J Med200370653553754112828224
   PubMed Web of Science ®Google Scholar
• National Kidney FoundationKDQOI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratificationAm J Kidney Dis2002392 Suppl 1s1s26611904577
   PubMed Web of Science ®Google Scholar
• GoASChertowGMFanDMcCullochCEHsuCYChronic kidney disease and the risks of death, cardiovascular events, and hospitalizationN Engl J Med2004351131296130515385656
   PubMed Web of Science ®Google Scholar
• KeithDSNicholsGAGullionCMBrownJBSmithDHLongitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organizationArch Intern Med2004164665966315037495
   PubMed Web of Science ®Google Scholar
• MatsushitaKvan der VeldeMAstorBCChronic Kidney Disease Prognosis ConsortiumAssociation of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisLancet201037597312073208120483451
   PubMed Web of Science ®Google Scholar
• TonelliMWiebeNCulletonBChronic kidney disease and mortality risk: a systematic reviewJ Am Soc Nephrol20061772034204716738019
   PubMed Web of Science ®Google Scholar
• Di AngelantonioEChowdhuryRSarwarNAspelundTDaneshJGudnasonVChronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort studyBMJ2010341c498620884698
   PubMed Web of Science ®Google Scholar
• HerzogCAKidney disease in cardiologyNephrol Dial Transplant2009241343719028753
   PubMed Web of Science ®Google Scholar
• NagataMNinomiyaTKiyoharaYEPOCH-JAPAN Research GroupPrediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in JapanAm J Epidemiol2013178111123752917
   PubMed Web of Science ®Google Scholar
• HemmelgarnBRMannsBJLloydAAlberta Kidney Disease NetworkRelation between kidney function, proteinuria, and adverse outcomesJAMA2010303542342920124537
   PubMed Web of Science ®Google Scholar
• KannelWBStampferMJCastelliWPVerterJThe prognostic significance of proteinuria: the Framingham studyAm Heart J19841085134713526496291
   PubMed Web of Science ®Google Scholar
• MatsushitaKvan der VeldeMAstorBCChronic Kidney Disease Prognosis ConsortiumAssociation of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisLancet201037597312073208120483451
   PubMed Web of Science ®Google Scholar
• HillegeHLFidlerVDiercksGFPrevention of Renal and Vascular End Stage Disease (PREVEND) Study GroupUrinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general populationCirculation2002106141777178212356629
   PubMed Web of Science ®Google Scholar
• IrieFIsoHSairenchiTThe relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general populationKidney Int20066971264127116501489
   PubMed Web of Science ®Google Scholar
• InoueTIsekiKHigashiuesatoYProteinuria as a significant determinant of hypertension in a normotensive screened cohort in Okinawa, JapanHypertens Res200629968769317249524
   PubMed Web of Science ®Google Scholar
• WangZHoyWEAlbuminuria and incident coronary heart disease in Australian Aboriginal peopleKidney Int20056831289129316105063
   PubMed Web of Science ®Google Scholar
• DamsgaardEMFrølandAJørgensenODMogensenCEMicroalbuminuria as predictor of increased mortality in elderly peopleBMJ199030067202973002106959
   PubMed Web of Science ®Google Scholar
• BelloAKHemmelgarnBLloydAAlberta Kidney Disease NetworkAssociations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomesClin J Am Soc Nephrol2011661418142621527648
   PubMed Web of Science ®Google Scholar
• PerkovicVVerdonCNinomiyaTThe relationship between proteinuria and coronary risk: a systematic review and meta-analysisPLoS Med2008510e20718942886
   PubMed Web of Science ®Google Scholar
• GersteinHCMannJFYiQHOPE Study InvestigatorsAlbuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individualsJAMA2001286442142611466120
   PubMed Web of Science ®Google Scholar
• HillegeHLJanssenWMBakAAPrevend Study GroupMicroalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidityJ Intern Med2001249651952611422658
   PubMed Web of Science ®Google Scholar
• WachtellKIbsenHOlsenMHAlbuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE studyAnn Intern Med20031391190190614644892
   PubMed Web of Science ®Google Scholar
• WachtellKOlsenMHDahlöfBMicroalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE studyJ Hypertens200220340541211875307
   PubMed Web of Science ®Google Scholar
• LeeMSaverJLChangKHLiaoHWChangSCOvbiageleBImpact of microalbuminuria on incident stroke: a meta-analysisStroke201041112625263120930164
   PubMed Web of Science ®Google Scholar
• NinomiyaTPerkovicVVerdonCProteinuria and stroke: a meta-analysis of cohort studiesAm J Kidney Dis200953341742519070947
   PubMed Web of Science ®Google Scholar
• JensenJSFeldt-RasmussenBStrandgaardSSchrollMBorch-JohnsenKArterial hypertension, microalbuminuria, and risk of ischemic heart diseaseHypertension200035489890310775558
   PubMed Web of Science ®Google Scholar
• NobakhthaghighiNKamgarMBekheirniaMRMcFannKEstacioRSchrierRWRelationship between urinary albumin excretion and left ventricular mass with mortality in patients with type 2 diabetesClin J Am Soc Nephrol2006161187119017699346
   PubMed Web of Science ®Google Scholar
• PostWSBlumenthalRSWeissJLSpot urinary albumin-creatinine ratio predicts left ventricular hypertrophy in young hypertensive African-American menAm J Hypertens200013111168117211078176
   PubMed Web of Science ®Google Scholar
• Dell’omoGGiorgiDDi BelloVMarianiMPedrinelliRBlood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive menJ Intern Med20032541768412823644
   PubMed Web of Science ®Google Scholar
• SolomonSDLinJSolomonCGPrevention of Events With ACE Inhibition (PEACE) InvestigatorsInfluence of albuminuria on cardiovascular risk in patients with stable coronary artery diseaseCirculation2007116232687269318025537
   PubMed Web of Science ®Google Scholar
• JosePSkaliHAnavekarNIncrease in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarctionJ Am Soc Nephrol200617102886289116928807
   PubMed Web of Science ®Google Scholar
• NazerBRayKKMurphySAGibsonCMCannonCPUrinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudyJ Thromb Thrombolysis201336323323923212806
   PubMed Web of Science ®Google Scholar
• MogensenCEMicroalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetesN Engl J Med198431063563606690964
   PubMed Web of Science ®Google Scholar
• MessentJWElliottTGHillRDJarrettRJKeenHVibertiGCPrognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up studyKidney Int19924148368391513106
   PubMed Web of Science ®Google Scholar
• Borch-JohnsenKAndersenPKDeckertTThe effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitusDiabetologia19852885905964054448
   PubMed Web of Science ®Google Scholar
• LinCCChenCCKungPTJoint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes StudyCardiovasc Diabetol20121113123083001
   PubMed Web of Science ®Google Scholar
• AnavekarNSGansDJBerlTPredictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuriaKidney Int Suppl2004S50S5515485418
   PubMed Web of Science ®Google Scholar
• DinneenSFGersteinHCThe association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literatureArch Intern Med199715713141314189224218
   PubMed Web of Science ®Google Scholar
• StadlerMAuingerMAnderwaldCLong-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitusJ Clin Endocrinol Metab200691103814382016882744
   PubMed Web of Science ®Google Scholar
• de JongPEGansevoortRTBakkerSJMacroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?J Nephrol200720437538017879201
   PubMed Web of Science ®Google Scholar
• RossingPHougaardPBorch-JohnsenKParvingHHPredictors of mortality in insulin dependent diabetes: 10 year observational follow up studyBMJ199631370607797848842069
   PubMed Web of Science ®Google Scholar
• de ZeeuwDRemuzziGParvingHHAlbuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyCirculation2004110892192715302780
   PubMed Web of Science ®Google Scholar
• MorrishNJStevensLKFullerJHJarrettRJKeenHRisk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in DiabeticsDiabetologia19913485905941936663
   PubMed Web of Science ®Google Scholar
• EscobedoJRanaJSLombarderoMSBARI 2D Study GroupAssociation between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D studyMayo Clin Proc2010851414620042560
   PubMed Web of Science ®Google Scholar
• LiuJERobbinsDCPalmieriVAssociation of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart StudyJ Am Coll Cardiol200341112022202812798576
   PubMed Web of Science ®Google Scholar
• VaurLGueretPLievreMChabaudSPassaPDIABHYCAR Study Group (type 2 DIABetes, Hypertension, CARdiovascular Events and Ramipril) studyDevelopment of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) studyDiabetes Care200326385586012610049
   PubMed Web of Science ®Google Scholar
• CarrAAKoweyPRDevereuxRBHospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studiesAm J Cardiol200596111530153616310435
   PubMed Web of Science ®Google Scholar
• MacDonaldMRPetrieMCHawkinsNMDiabetes, left ventricular systolic dysfunction, and chronic heart failureEur Heart J200829101224124018424786
   PubMed Web of Science ®Google Scholar
• On the horizon in heart failureLancet2011378979263721856462
   PubMed Web of Science ®Google Scholar
• van de WalRMAsselbergsFWPlokkerHWHigh prevalence of microalbuminuria in chronic heart failure patientsJ Card Fail200511860260616230263
   PubMed Web of Science ®Google Scholar
• JacksonCESolomonSDGersteinHCCHARM Investigators and CommitteesAlbuminuria in chronic heart failure: prevalence and prognostic importanceLancet2009374968954355019683640
   PubMed Web of Science ®Google Scholar
• JacksonCEMacDonaldMRPetrieMCALiskiren Observation of heart Failure Treatment (ALOFT) investigatorsAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment studyEur J Heart Fail201113774675421459891
   PubMed Web of Science ®Google Scholar
• SmithDHThorpMLGurwitzJHChronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE StudyCirc Cardiovasc Qual Outcomes20136333334223685625
   PubMed Web of Science ®Google Scholar
• DiercksGFvan BovenAJHillegeHLMicroalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) studyEur Heart J200021231922192711071797
   PubMed Web of Science ®Google Scholar
• BigazziRBianchiSNenciRBaldariDBaldariGCampeseVMIncreased thickness of the carotid artery in patients with essential hypertension and microalbuminuriaJ Hum Hypertens19959108278338576899
   PubMed Web of Science ®Google Scholar
• MykkänenLZaccaroDJO’LearyDHHowardGRobbinsDCHaffnerSMMicroalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS)Stroke1997289171017169303013
   PubMed Web of Science ®Google Scholar
• KramerHJacobsDRBildDUrine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of AtherosclerosisHypertension2005461384315956113
   PubMed Web of Science ®Google Scholar
• UpadhyayAHwangSJMitchellGFArterial stiffness in mild-to-moderate CKDJ Am Soc Nephrol20092092044205319608701
   PubMed Web of Science ®Google Scholar
• DeckertTFeldt-RasmussenBBorch-JohnsenKJensenTKofoed-EnevoldsenAAlbuminuria reflects widespread vascular damage. The Steno hypothesisDiabetologia19893242192262668076
   PubMed Web of Science ®Google Scholar
• HellemonsMELambers HeerspinkHJGansevoortRTde ZeeuwDBakkerSJHigh-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetesJ Hypertens201331480581223425705
   PubMed Web of Science ®Google Scholar
• TsioufisCDimitriadisKChatzisDRelation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertensionAm J Cardiol200596794695116188522
   PubMed Web of Science ®Google Scholar
• YilmazMISonmezASaglamMADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunctionJ Am Soc Nephrol200819238839518199801
   PubMed Web of Science ®Google Scholar
• PedrinelliRGiampietroOCarmassiFMicroalbuminuria and endothelial dysfunction in essential hypertensionLancet1994344891414187912295
   PubMed Web of Science ®Google Scholar
• ZhuXWuSDahutWLParikhCRRisks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysisAm J Kidney Dis200749218619317261421
   PubMed Web of Science ®Google Scholar
• StehouwerCDGallMATwiskJWKnudsenEEmeisJJParvingHHIncreased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of deathDiabetes20025141157116511916939
   PubMed Web of Science ®Google Scholar
• KnöblPSchernthanerGSchnackCThrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patientsDiabetologia19933610104510508243853
   PubMed Web of Science ®Google Scholar
• HiranoTKashiwazakiKMoritomoYNaganoSAdachiMAlbuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patientsDiabetes Res Clin Pract199736111189187410
   PubMed Web of Science ®Google Scholar
• MykkänenLZaccaroDJWagenknechtLERobbinsDCGabrielMHaffnerSMMicroalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis studyDiabetes19984757938009588452
   PubMed Web of Science ®Google Scholar
• BianchiSBigazziRValtrianiCElevated serum insulin levels in patients with essential hypertension and microalbuminuriaHypertension1994236 Pt 16816878206563
   PubMed Web of Science ®Google Scholar
• JeeSHBoulwareLEGuallarESuhIAppelLJMillerERDirect, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) studyArch Intern Med2005165192299230416246998
   PubMedGoogle Scholar
• FarasatSMValdesCShettyVIs longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?Hypertension201055241542120008676
   PubMed Web of Science ®Google Scholar
• BianchiSBigazziRCaiazzaACampeseVMA controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney diseaseAm J Kidney Dis200341356557012612979
   PubMed Web of Science ®Google Scholar
• RavidMBroshDRavid-SafranDLevyZRachmaniRMain risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemiaArch Intern Med1998158999810049588433
   PubMedGoogle Scholar
• RitzEVibertiGCRuilopeLMDeterminants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyDiabetologia2010531495719876613
   PubMed Web of Science ®Google Scholar
• Pinto-SietsmaSJNavisGJanssenWMde ZeeuwDGansROde JongPEPREVEND Study GroupA central body fat distribution is related to renal function impairment, even in lean subjectsAm J Kidney Dis200341473374112666059
   PubMed Web of Science ®Google Scholar
• FortJChronic renal failure: a cardiovascular risk factorKidney Int Suppl2005S25S2916336573
   PubMedGoogle Scholar
• RedonJRoviraEMirallesAJulveRPascualJMFactors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertensionHypertension200239379479811897766
   PubMed Web of Science ®Google Scholar
• PalatiniPMorminoPDorigattiFHARVEST Study GroupGlomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVESTKidney Int200670357858416788693
   PubMed Web of Science ®Google Scholar
• ParvingHHLewisJBRavidMRemuzziGHunsickerLGDEMAND investigatorsPrevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspectiveKidney Int200669112057206316612330
   PubMed Web of Science ®Google Scholar
• IbsenHOlsenMHWachtellKDoes albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE studyDiabetes Care200629359560016505512
   PubMed Web of Science ®Google Scholar
• AsselbergsFWDiercksGFHillegeHLPrevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) InvestigatorsEffects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuriaCirculation2004110182809281615492322
   PubMed Web of Science ®Google Scholar
• PetersonJCAdlerSBurkartJMBlood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease StudyAnn Intern Med1995123107547627574193
   PubMed Web of Science ®Google Scholar
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupBMJ199831771607037139732337
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work GroupKDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney Int Suppl2013311150
   Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceNICE Clinical Guideline 66: The Management of Type 2 Diabetes Available from: http://www.nice.org.uk/nicemedia/pdf/cg66niceguideline.pdfAccessed November 27, 2013
   Google Scholar
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)Lancet19973499069185718639217756
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGBainRPRohdeRDThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study GroupN Engl J Med199332920145614628413456
   PubMed Web of Science ®Google Scholar
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsLancet2000355920025325910675071
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWRCollaborative Study GroupRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med20013451285186011565517
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEde ZeeuwDRENAAL Study InvestigatorsEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Engl J Med20013451286186911565518
   PubMed Web of Science ®Google Scholar
• MannJFGersteinHCPogueJBoschJYusufSRenal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trialAnn Intern Med2001134862963611304102
   PubMed Web of Science ®Google Scholar
• DahlöfBDevereuxRBKjeldsenSELIFE Study GroupCardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet20023599311995100311937178
   PubMed Web of Science ®Google Scholar
• LindholmLHIbsenHDahlöfBLIFE Study GroupCardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet200235993111004101011937179
   PubMed Web of Science ®Google Scholar
• ParvingHHLehnertHBröchner-MortensenJGomisRAndersenSArnerPIrbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study GroupThe effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesN Engl J Med20013451287087811565519
   PubMed Web of Science ®Google Scholar
• HallerHItoSIzzoJLROADMAP Trial InvestigatorsOlmesartan for the delay or prevention of microalbuminuria in type 2 diabetesN Engl J Med20113641090791721388309
   PubMed Web of Science ®Google Scholar
• ONTARGET InvestigatorsYusufSTeoKKPogueJDyalLCoplandISchumacherHDagenaisGSleightPAndersonCTelmisartan, ramipril, or both in patients at high risk for vascular eventsN Engl J Med2008358151547155918378520
   PubMed Web of Science ®Google Scholar
• MannJSchmiederRMcQueenMONTARGET investigatorsRenal outcomes with telimsartan, ramipril or both in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double blind, controlled trialLancet2008372963854755318707986
   PubMed Web of Science ®Google Scholar
• NavaneethanSDNigwekarSUSehgalARStrippoliGFAldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysisClin J Am Soc Nephrol20094354255119261819
   PubMed Web of Science ®Google Scholar
• StantonAJensenCNussbergerJO’BrienEBlood pressure lowering in essential hypertension with an oral renin inhibitor, aliskirenHypertension20034261137114314597641
   PubMed Web of Science ®Google Scholar
• StrasserRHPuigJGFarsangCCroketMLiJvan IngenHA comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertensionJ Hum Hypertens2007211078078717541390
   PubMed Web of Science ®Google Scholar
• VillamilAChrysantSGCalhounDRenin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazideJ Hypertens200725121722617143194
   PubMed Web of Science ®Google Scholar
• UresinYTaylorAAKiloCEfficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertensionJ Renin Angiotensin Aldosterone Syst20078419019818205098
   PubMed Web of Science ®Google Scholar
• ParvingHHPerssonFLewisJBLewisEJHollenbergNKAVOID Study InvestigatorsAliskiren combined with losartan in type 2 diabetes and nephropathyN Engl J Med2008358232433244618525041
   PubMed Web of Science ®Google Scholar
• OparilSYarowsSAPatelSFangHZhangJSatlinAEfficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trialLancet2007370958322122917658393
   PubMed Web of Science ®Google Scholar
• LiSChenYYangWEffects of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney diseaseBMC Nephrol2012138922917002
   PubMed Web of Science ®Google Scholar
• LópezVMartinMCobeloCRenin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipientsTransplant Proc20104282883288520970559
   PubMed Web of Science ®Google Scholar
• ParvingHHBrennerBMMcMurrayJJALTITUDE InvestigatorsCardiorenal end points in a trial of aliskiren for type 2 diabetesN Engl J Med2012367232204221323121378
   PubMed Web of Science ®Google Scholar
• ShiigaiTShichiriMLate escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal diseaseAm J Kidney Dis200137347748311228170
   PubMed Web of Science ®Google Scholar
• WenzelRRLittkeTKuranoffSSPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study InvestigatorsAvosentan reduces albumin excretion in diabetics with macroalbuminuriaJ Am Soc Nephrol200920365566419144760
   PubMed Web of Science ®Google Scholar
• KohanDEPritchettYMolitchMAddition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathyJ Am Soc Nephrol201122476377221372210
   PubMed Web of Science ®Google Scholar
• DouglasKO’MalleyPGJacksonJLMeta-analysis: the effect of statins on albuminuriaAnn Intern Med2006145211712416847294
   PubMed Web of Science ®Google Scholar
• StrippoliGFNavaneethanSDJohnsonDWEffects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsBMJ2008336764564565118299289
   PubMed Web of Science ®Google Scholar
• LeeTMSuSFTsaiCHEffect of pravastatin on proteinuria in patients with well-controlled hypertensionHypertension2002401677312105140
   PubMed Web of Science ®Google Scholar
• RemuzziGCigarette smoking and renal function impairmentAm J Kidney Dis199933480781310196031
   PubMed Web of Science ®Google Scholar
• OberaiBAdamsCWHighOBMyocardial and renal arteriolar thickening in cigarette smokersAtherosclerosis19845221851906477670
   PubMed Web of Science ®Google Scholar
• OrthSRHallanSISmoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients – absence of evidence or evidence of absence?Clin J Am Soc Nephrol20083122623618003763
   PubMed Web of Science ®Google Scholar
• TozawaMIsekiKIsekiCOshiroSIkemiyaYTakishitaSInfluence of smoking and obesity on the development of proteinuriaKidney Int200262395696212164878
   PubMed Web of Science ®Google Scholar
• MoralesEHuertaAGutiérrezEGutiérrez SolísESeguraJPragaMThe antiproteinuric effect of the blockage of the reninangiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective?Nefrologia2009295421429 Spanish19820754
   PubMed Web of Science ®Google Scholar
• PragaMTherapeutic measures in proteinuric nephropathyKidney Int Suppl2005S137S14116336567
   PubMedGoogle Scholar
• PragaMHernándezEAndrésALeónMRuilopeLMRodicioJLEffects of body-weight loss and captopril treatment on proteinuria associated with obesityNephron199570135417617115
   PubMed Web of Science ®Google Scholar
• SlagmanMCWaandersFHemmelderMHHOlland NEphrology STudy GroupModerate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trialBMJ2011343d436621791491
   PubMed Web of Science ®Google Scholar
• VegterSPernaAPostmaMJNavisGRemuzziGRuggenentiPSodium intake, ACE inhibition, and progression to ESRDJ Am Soc Nephrol201223116517322135311
   PubMed Web of Science ®Google Scholar
• GulatiVWhiteWBReview of the state of renal nerve ablation for patients with severe and resistant hypertensionJ Am Soc Hypertens2013
   Web of Science ®Google Scholar
• EslerMDKrumHSobotkaPASchlaichMPSchmiederREBöhmMSymplicity HTN-2 InvestigatorsRenal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialLancet201037697561903190921093036
   PubMed Web of Science ®Google Scholar
• Symplicity HTN-1 InvestigatorsCatheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 monthsHypertension201157591191721403086
   PubMed Web of Science ®Google Scholar
• BrandtMCMahfoudFRedaSRenal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertensionJ Am Coll Cardiol2012591090190922381425
   PubMed Web of Science ®Google Scholar
• MahfoudFCremersBJankerJRenal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertensionHypertension201260241942422733462
   PubMed Web of Science ®Google Scholar
• BoulwareLEJaarBGTarver-CarrMEBrancatiFLPoweNRScreening for proteinuria in US adults: a cost-effectiveness analysisJAMA2003290233101311414679273
   PubMed Web of Science ®Google Scholar
• AtthobariJAsselbergsFWBoersmaCPREVEND IT Study GroupCost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)Clin Ther200628343244416750458
   PubMed Web of Science ®Google Scholar